Scientific and Medical Director, Critical Care,
Octapharma, United States
Dr. Adam Gerber, MD, PhD, is a leading physician-scientist and the Medical & Scientific Director for Critical Care at Octapharma USA. With over a decade of multidisciplinary experience spanning research, industry, and academic medicine, Dr. Gerber specializes in developing innovative therapies for critical care, trauma, and acute lung injury. His expertise in pulmonary and inflammatory biology, combined with his leadership in advancing products from discovery to clinical application, positions him at the forefront of advancing blood substitutes and therapies for acute hemorrhage when traditional blood products are unavailable.
Disclosure information not submitted.
Advancing Battlefield Care: Freeze-Dried Plasma and Fibrinogen for Combat Trauma
Wednesday, May 7, 2025
10:45 - 11:05 East Coast USA Time